Literature DB >> 26607343

Procalcitonin to guide antibiotic therapy in the ICU.

Nicolas Bréchot1, Guillaume Hékimian2, Jean Chastre2, Charles-Edouard Luyt2.   

Abstract

The serum procalcitonin (PCT) concentration reflects both the systemic response to bacterial infection and its severity. However, its accuracy in distinguishing intensive care unit (ICU) patients with and without infection remains low owing to a lack of specificity and the time lapse between infection onset and the PCT rise. Hence, PCT cannot be used as a marker to start or withhold antibiotic therapy for ICU patients. However, the kinetics of the PCT concentration decrease under antibiotic therapy can adequately monitor infection evolution with therapy and can help to customise antibiotic duration. PCT-guided algorithms to guide antibiotic discontinuation were able to shorten antibiotic duration without impacting patient outcomes in several multicentre randomised studies. Notably, antibiotics can be stopped very early when PCT is low and remains low as this indicates that bacterial infection is unlikely. When PCT falls to <0.5 ng/mL or >80% from its peak value, antibiotics for non-localised infections can safely be stopped.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotic stewardship; Nosocomial infection; Procalcitonin; Sepsis

Mesh:

Substances:

Year:  2015        PMID: 26607343     DOI: 10.1016/j.ijantimicag.2015.10.012

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  18 in total

Review 1.  [Patients with sepsis].

Authors:  M Oppert
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-09       Impact factor: 0.840

Review 2.  Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.

Authors:  Brenda Ng Andriolo; Regis B Andriolo; Reinaldo Salomão; Álvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2017-01-18

3.  Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

Authors:  Mohan Natesan; Enoka Corea; Shivankari Krishnananthasivam; Harindra Darshana Sathkumara; Jennifer L Dankmeyer; Beverly K Dyas; Kei Amemiya; Aruna Dharshan De Silva; Robert G Ulrich
Journal:  J Clin Microbiol       Date:  2017-02-08       Impact factor: 5.948

4.  Comparison of Procalcitonin Guidance-Administered Antibiotics with Standard Guidelines on Antibiotic Therapy in Children with Lower Respiratory Tract Infections: A Retrospective Study in China.

Authors:  Guo Wu; Gao Wu; Shuxie Wu; Hanbin Wu
Journal:  Med Princ Pract       Date:  2017-06-01       Impact factor: 1.927

5.  Early diagnosis of bacterial infection in patients with septicopyemia by laboratory analysis of PCT, CRP and IL-6.

Authors:  Liqin Gao; Xinghui Liu; Denghai Zhang; Fengxia Xu; Qing Chen; Ye Hong; Gang Feng; Qin Shi; Bin Yang; Limin Xu
Journal:  Exp Ther Med       Date:  2017-05-03       Impact factor: 2.447

6.  Clinical value of procalcitonin for suspected nosocomial bloodstream infection.

Authors:  Joo Kyoung Cha; Ki Hwan Kwon; Seung Joo Byun; Soo Ryeong Ryoo; Jeong Hyeon Lee; Jae-Woo Chung; Hee Jin Huh; Seok Lae Chae; Seong Yeon Park
Journal:  Korean J Intern Med       Date:  2017-11-08       Impact factor: 2.884

7.  Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock.

Authors:  Andreas Hohn; Nina Balfer; Bernhard Heising; Sabine Hertel; Jan C Wiemer; Marcel Hochreiter; Stefan Schröder
Journal:  Ann Intensive Care       Date:  2018-06-04       Impact factor: 6.925

8.  NF-кB increases LPS-mediated procalcitonin production in human hepatocytes.

Authors:  Yongfeng Bai; Jun Lu; Ying Cheng; Feng Zhang; Xueyu Fan; Yuanyuan Weng; Jin Zhu
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

9.  Procalcitonin as an Early Laboratory Marker of Sepsis in Neonates: Variation in Diagnostic Performance and Discrimination Value.

Authors:  Julia Omar; Salbiah Isa; Tuan Salwani Tuan Ismail; Najib Majdi Yaacob; Noor Azlin Azraini Che Soh
Journal:  Malays J Med Sci       Date:  2019-08-29

Review 10.  A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine.

Authors:  Anna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette; Marta Vecchi; Ilaria Coledan; Elda Righi; Evelina Tacconelli
Journal:  Ann Transl Med       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.